Treatment of Keratoconus With Advanced Corneal Crosslinking

U

Umeå University

Status

Completed

Conditions

Keratoconus

Treatments

Procedure: Corneal Crosslinking (CXL)
Procedure: Corneal reshaping/crosslinking (CRXL)

Study type

Interventional

Funder types

Other

Identifiers

NCT02425150
CRXL

Details and patient eligibility

About

The purpose of this study was to determine whether mechanical compression of the cornea during corneal crosslinking for keratoconus using a sutured rigid contact lens can improve the optical outcomes of the treatment.

Full description

The study is designed as a prospective, open, randomized controlled trial involving patients aged 18-28 years of both genders with uni- or bilateral keratoconus planned for routine corneal crosslinking at the Department of Ophthalmology, Umeå University Hospital, Umeå, Sweden. The study involves 30+30 eyes with keratoconus, which are randomized to receive either conventional corneal crosslinking (n=30) using the Dresden protocol or a modified treatment - corneal reshaping and crosslinking (n=30), where a rigid contact lens is sutured to the cornea during the treatment to flatten the corneal curvature and potentially improve the optical outcome after the treatment. Patients are randomized utilizing a list of unique random numbers between 1 and 60. All patients are informed about the procedures before consenting to participate in the study. The study also involves 60 eyes of healthy age- and sex-matched control subjects. At baseline, before treatment, each eye is evaluated with autorefractometer measurement, best spectacle-corrected LogMAR visual acuity, Pentacam Scheimpflug photography, Goldmann applanation tonometry and biomicroscopy. The corneal biomechanical characteristics are assessed with applanation resonance tonometry and the ocular response analyzer. The investigations are repeated at 1 month, 6 months, 2 years and 5 years after the treatment.

Enrollment

120 patients

Sex

All

Ages

18 to 28 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients planned for corneal crosslinking.
  • Progressive keratoconus documented with Scheimpflug photography using the Pentacam Scheimflug camera and/or repeated subjective refraction and keratometry.
  • A keratoconus diagnosis based on the Amsler-Krumeich grading and the "Total Deviation" KC quantification value from the "Belin-Ambrosio enhanced ectasia" measurements of the Pentacam Scheimpflug camera, and an altered red reflex and/or an irregular cornea seen as distortion of the keratometric mires.
  • Minimum corneal thickness of 400 µm at the thinnest point after epithelial removal.
  • 18-28 years of age
  • No ocular abnormalities except keratoconus
  • No previous ocular surgery
  • No cognitive insufficiency interfering with the informed consent.

Exclusion criteria

  • Age under 18 or over 28
  • Any corneal abnormalities except keratoconus
  • Previous ocular surgery
  • Cognitive insufficiency.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 4 patient groups

Corneal reshaping/crosslinking (CRXL)
Experimental group
Description:
Corneal crosslinking with compression of the cornea using a sutured rigid contact lens during the treatment.
Treatment:
Procedure: Corneal reshaping/crosslinking (CRXL)
Corneal crosslinking (CXL)
Active Comparator group
Description:
Standard corneal crosslinking using the Dresden protocol.
Treatment:
Procedure: Corneal Crosslinking (CXL)
Control group to CRXL
No Intervention group
Description:
Healthy subjects, age- and sex-matched to the CRXL group.
Control group to CXL
No Intervention group
Description:
Healthy subjects, age- and sex-matched to the CXL group.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems